BlackRock’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,389,788
| Closed | -$428M | – | 5554 |
|
|
2024
Q4 | $428M | Buy |
8,389,788
+64,682
| +0.8% | +$3.18M | 0.01% | 1189 |
|
|
2024
Q3 | $343M | Sell |
8,325,106
-38,565
| -0.5% | -$1.85M | 0.01% | 1339 |
|
|
2024
Q2 | $403M | Sell |
8,363,671
-118,708
| -1% | -$5.26M | 0.01% | 1149 |
|
|
2024
Q1 | $407M | Buy |
8,482,379
+1,785,781
| +27% | +$95.4M | 0.01% | 1177 |
|
|
2023
Q4 | $435M | Buy |
6,696,598
+210,676
| +3% | +$12.7M | 0.01% | 1118 |
|
|
2023
Q3 | $424M | Buy |
6,485,922
+100,116
| +2% | +$6.3M | 0.01% | 1015 |
|
|
2023
Q2 | $371M | Buy |
6,385,806
+733,738
| +13% | +$46.3M | 0.01% | 1142 |
|
|
2023
Q1 | $349M | Sell |
5,652,068
-19,032
| -0.3% | -$1.14M | 0.01% | 1164 |
|
|
2022
Q4 | $360M | Buy |
5,671,100
+255,304
| +5% | +$18.5M | 0.01% | 1105 |
|
|
2022
Q3 | $393M | Buy |
5,415,796
+858,266
| +19% | +$63.9M | 0.01% | 977 |
|
|
2022
Q2 | $310M | Buy |
4,557,530
+2,236,840
| +96% | +$161M | 0.01% | 1205 |
|
|
2022
Q1 | $210M | Buy |
2,320,690
+1,955
| +0.1% | +$160K | 0.01% | 1638 |
|
|
2021
Q4 | $212M | Buy |
2,318,735
+93,071
| +4% | +$7.98M | 0.01% | 1694 |
|
|
2021
Q3 | $181M | Buy |
2,225,664
+424,329
| +24% | +$35.7M | 0.01% | 1794 |
|
|
2021
Q2 | $168M | Buy |
1,801,335
+700,745
| +64% | +$67.9M | ﹤0.01% | 1904 |
|
|
2021
Q1 | $118M | Buy |
1,100,590
+507,832
| +86% | +$52.7M | ﹤0.01% | 2098 |
|
|
2020
Q4 | $51.7M | Buy |
592,758
+47,455
| +9% | +$3.35M | ﹤0.01% | 2451 |
|
|
2020
Q3 | $37.6M | Buy |
+545,303
| New | +$35.1M | ﹤0.01% | 2461 |
|
Other funds holding NARI
SA
IA
TCWM
PS